Accelerating Investee Company Growth Through the Deployment of Capital and Talent and Subsequent Sale
First written in FY2016. 30 of 37 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-08-04.
14 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「During the consolidated fiscal year, capital gains were realized through 3 appropriate trade sales based on the medium-term management plan.」
Regarding the realization of returns from portfolio companies based on the medium-term management plan, capital gains were realized through 3 trade sales during the fiscal year. - FY2026-H1AdvancedAnnual report
「During the interim consolidated period, capital gains were realized through 1 trade sale.」
Within the investment cycle of providing support to portfolio companies and then exiting, capital gains were realized through 1 trade sale during the interim consolidated period. - FY2025AdvancedAnnual report
「During the consolidated fiscal year, capital gains were realized through 3 appropriate trade sales based on the medium-term management plan.」
Regarding the realization of returns from portfolio companies based on the medium-term management plan, capital gains were realized through 3 trade sales during the fiscal year. - FY2025-H1AdvancedAnnual report
「During the interim consolidated period, capital gains were realized through 2 trade sales based on the medium-term management plan.」
Regarding the realization of returns from portfolio companies based on the medium-term management plan, capital gains were realized through 2 trade sales during the interim consolidated period. - FY2024AdvancedAnnual report
「During the consolidated fiscal year, capital gains were realized through appropriate trade sales based on the medium-term management plan, while an impairment loss of ¥1,792 million was recorded due to declines in the value of 18 portfolio companies.」
Returns were realized through trade sales based on the medium-term management plan. Impairment losses also arose due to declines in the value of 18 portfolio companies. - FY2024-Q3AdvancedAnnual report
「During the cumulative third quarter, we realized capital gains and other gains through trade sales, while recording an impairment loss of ¥831 million due to declines in the value of 9 portfolio companies.」
Within the cycle of providing support to portfolio companies and then exiting, capital gains and other gains were realized through trade sales. An impairment loss of ¥831 million was also recorded due to declines in the value of 9 portfolio companies. - FY2024-Q2AdvancedAnnual report
「During the cumulative second quarter, we realized capital gains and other gains through trade sales, while also recording an impairment loss of ¥390 million due to declines in the value of 3 portfolio companies.」
Capital gains were realized through trade sales of portfolio companies, advancing the cycle of investing in and developing them and then exiting. An impairment loss of ¥390 million was also recorded due to declines in the value of 3 portfolio companies. - FY2024-Q1AdvancedAnnual report
「During the cumulative first quarter, we realized capital gains and other gains through trade sales.」
Within the investment cycle of providing support to portfolio companies and then exiting, capital gains and other gains were realized through trade sales in the first quarter as well. - FY2023AdvancedAnnual report
「During the consolidated fiscal year, capital gains were realized through active trade sales based on the medium-term management plan, while impairment losses were also recorded due to declines in the value of certain portfolio companies.」
Active trade sales were conducted based on the medium-term management plan, resulting in revenue of ¥1,915 million and segment profit of ¥375 million in the venture investment segment for the fiscal year. Impairment losses were also recognized for certain portfolio companies. - FY2023-Q3AdvancedAnnual report
「During the consolidated third quarter, we realized capital gains through multiple trade sales, while also recording impairment losses due to declines in the value of portfolio companies.」
Capital gains were realized through multiple trade sales, advancing the cycle of investing in and developing portfolio companies and then exiting. Impairment losses were also recorded due to declines in the value of portfolio companies. - FY2023-Q2AdvancedAnnual report
「During the consolidated second quarter, we realized capital gains through multiple trade sales, while recording an impairment loss due to declines in the value of portfolio companies.」
Within the investment cycle of providing portfolio companies with funding and personnel and then exiting, capital gains were realized through multiple trade sales during the cumulative second quarter. - FY2023-Q1AdvancedAnnual report
「During the cumulative first quarter, we realized capital gains and other gains through multiple trade sales.」
Within the investment cycle of providing portfolio companies with funding and personnel and then exiting, capital gains and other gains were realized through multiple trade sales in the first quarter. - FY2022AdvancedAnnual report
「Although multiple capital gains were realized through the sale of shares in connection with the IPO of Slogan Inc. and trade sales of shares in Indian portfolio companies, the amount of capital gains fell short of expectations because a major company that had been expected to conduct an IPO withdrew its listing application immediately before the fiscal year-end.」
Multiple capital gains were realized through the sale associated with Slogan Inc.'s IPO and a trade sale by an Indian portfolio company, while the withdrawal of a major company's listing application resulted in performance falling short of expectations. - FY2022-Q3AdvancedAnnual report
「During the consolidated third quarter, we realized capital gains from the sale of shares in connection with the IPO of Slogan Inc. and from a trade sale by an Indian portfolio company.」
Capital gains were realized from the sale of shares in connection with a portfolio company's IPO and from a trade sale by an Indian portfolio company. - FY2022-Q1RestatedAnnual report
「As the main capital gains expected during the current consolidated fiscal year are concentrated in the second half, there were no significant realizations or impairment losses during the cumulative first quarter.」
The main capital gains are expected to be concentrated in the second half, and there were no significant realizations or impairment losses in the first quarter. The investment and exit cycle continues to be described. - FY2021-Q3AdvancedAnnual report
「Regarding existing venture investments, we provide funding and personnel to companies where our in-depth support is expected to accelerate growth. During the cumulative third quarter, we completed multiple exits through trade sales and other transactions, while recording impairment losses and other items due to declines in the value of 5 portfolio companies.」
Funding and personnel were provided to portfolio companies and multiple exits through trade sales were completed, while the number of companies affected by value declines increased from 3 in the previous quarter to 5, resulting in the recognition of impairment losses and other items. - FY2021-Q2AdvancedAnnual report
「Regarding existing venture investments, we provide funding and personnel to companies where our in-depth support is expected to accelerate growth. During the cumulative second quarter, we completed multiple exits through trade sales and other transactions, while recording impairment losses and other items due to declines in the value of 3 portfolio companies.」
The cycle of providing portfolio companies with funding and personnel and then exiting continued, with exits through multiple trade sales and other transactions completed. - FY2021-Q1AdvancedAnnual report
「Regarding existing venture investments, we provide funding and personnel at stages where our in-depth support is expected to accelerate growth, and subsequently proceed with exits. During the cumulative first quarter, we completed multiple exits through trade sales and other transactions, while recording an impairment loss on operating investment securities due to a decline in the value of 1 portfolio company.」
The cycle of providing portfolio companies with funding and personnel and then exiting continued, with multiple exits through trade sales and other transactions completed in the first quarter. An impairment loss was also recorded due to a decline in the value of 1 portfolio company. - FY2020-Q3AdvancedAnnual report
「Regarding existing venture investments, we provide funding and personnel at stages where our in-depth support is expected to accelerate growth, and subsequently proceed with exits. During the cumulative third quarter, in addition to multiple exits through trade sales, 1 portfolio company completed an IPO, while provisions for investment losses and other items were recorded due to declines in the value of 2 portfolio companies.」
The investment cycle of providing funding and personnel and then exiting continued, with multiple trade sales and an IPO by 1 portfolio company completed. - FY2020-Q2RestatedAnnual report
「Regarding existing venture investments, we provide funding and personnel at stages where our in-depth support is expected to accelerate growth, and subsequently proceed with exits. During the cumulative second quarter, we completed multiple exits through trade sales and other transactions, while recording provisions for investment losses and other items due to declines in the value of 2 portfolio companies.」
The investment cycle of providing portfolio companies with funding and personnel and then exiting, as well as multiple trade sales, continues to be reported. The decline in the value of 2 portfolio companies was recorded in t18 as an investment valuation risk. - FY2020-Q1AdvancedAnnual report
「Regarding existing venture investments, we provide funding and personnel at stages where our in-depth support is expected to accelerate growth, and subsequently proceed with exits. During the cumulative first quarter, we completed multiple exits through trade sales and other transactions.」
The investment cycle of providing portfolio companies with funding and personnel and then exiting was continued, with multiple exits through trade sales and other transactions completed in the first quarter. - FY2019ReframedAnnual report
「Regardless of whether an investee is included in the scope of consolidation or how segments are classified, our investments are made to develop portfolio companies, not to obtain control or consolidate them in itself. Accordingly, although investments in such portfolio companies may affect income or loss for the period, our policy is ultimately to sell all shares in these companies, as we do with other portfolio companies.」
The company clarifies its approach of investing in, developing and ultimately selling all shares in portfolio companies, without control or consolidation itself being the objective. - FY2019-Q3AdvancedAnnual report
「For existing portfolio ventures, we invest capital and human resources at stages where our extensive support is expected to accelerate growth, and then proceed with exits. During the nine-month period ended the current third quarter, in addition to several sales through trade sales, 1 portfolio company conducted an IPO.」
The investment cycle of selling portfolio companies after providing capital and human resources continued, and during the nine-month period ended the current third quarter, several portfolio companies were sold through trade sales and 1 portfolio company conducted an IPO. - FY2019-Q2AdvancedAnnual report
「For existing portfolio ventures, we invest capital and human resources at stages where our extensive support is expected to accelerate growth, and then proceed with exits. During the six-month period ended the current second quarter, we conducted several sales, including trade sales.」
The investment cycle of selling portfolio companies after providing capital and human resources continued, and several portfolio companies were sold through trade sales during the second quarter. - FY2019-Q1AdvancedAnnual report
「For existing portfolio ventures, we invest capital and human resources at stages where our extensive support is expected to accelerate growth, and then proceed with exits. During the three-month period ended the current first quarter, we conducted several sales, including trade sales.」
The investment cycle of selling portfolio companies after providing capital and human resources continued, and several portfolio companies were sold through trade sales during the first quarter. - FY2018AdvancedAnnual report
「For existing portfolio ventures, we invest capital and human resources at stages where our extensive support is expected to accelerate growth, and then proceed with exits. During the current fiscal year, 1 portfolio company conducted an IPO, and we also invested in and sold listed shares.」
The investment cycle of selling portfolio companies after providing capital and human resources continued, and 1 portfolio company conducted an IPO during the current fiscal year. - FY2018-Q3AdvancedAnnual report
「For existing portfolio companies, we invest capital and human resources at stages where our extensive support is expected to accelerate growth, and then proceed with exits. During the nine-month period ended the current third quarter, 1 company newly conducted an IPO.」
The investment cycle of providing portfolio companies with capital and human resources at their growth stage, followed by an exit, continued, and 1 additional company conducted an IPO. - FY2018-Q2RestatedAnnual report
「For existing portfolio companies, we invest capital and human resources at stages where our extensive support is expected to accelerate growth, and then proceed with exits. During the six-month period ended the current second quarter, none of the portfolio companies newly conducted an IPO.」
The company continues to describe an investment cycle of providing capital and human resources at a portfolio company's growth stage, followed by an exit. There were no new IPOs during the quarter. - FY2018-Q1RestatedAnnual report
「For existing portfolio ventures, we invest capital and human resources at stages where our extensive support is expected to accelerate growth, and then proceed with exits. During the three-month period ended the current first quarter, no portfolio companies newly conducted an IPO or were sold.」
The company continues to describe an investment cycle of providing capital and human resources at a portfolio company's growth stage, followed by an exit. There were no new IPOs or sales during the quarter. - FY2017-Q3AdvancedAnnual report
「For existing portfolio ventures, we invest capital and human resources at stages where our extensive support is expected to accelerate growth, and then proceed with exits. During the nine-month period ended the current third quarter, 1 additional portfolio company conducted an IPO, and we also invested in and sold listed shares.」
The cycle of providing portfolio companies with capital and human resources to accelerate growth, followed by an exit, continued, and 1 additional portfolio company conducted an IPO. - FY2017-Q2RestatedAnnual report
「For existing portfolio ventures, we invest capital and human resources at stages where our extensive support is expected to accelerate growth, and then proceed with exits. During the six-month period ended the current second quarter, none of the portfolio companies newly conducted an IPO, but we made additional investments in and sales of shares in listed portfolio companies.」
The investment cycle of providing capital and human resources at stages where growth acceleration is expected, followed by exits, as well as additional investments in and sales of shares in listed portfolio companies, continues to be reported. - FY2017-Q1AdvancedAnnual report
「For existing portfolio ventures, we invest capital and human resources at stages where our extensive support is expected to accelerate growth, and then proceed with exits. During the six-month period ended the current first quarter, none of the portfolio companies newly conducted an IPO, but we made additional investments in and sales of shares in listed portfolio companies.」
The investment cycle of selling existing portfolio companies after providing capital and human resources continued, and additional investments in and sales of shares in listed portfolio companies were made. There were no new IPOs. - FY2016First statedAnnual report
「For existing portfolio ventures, we invest capital and human resources at stages where our extensive support is expected to accelerate growth, and then proceed with exits. During the current fiscal year, 2 portfolio companies conducted IPOs, while the listing of 1 additional company that had been expected was delayed by 1 fiscal year.」
The company describes an investment cycle of providing capital and human resources at stages where growth acceleration is expected, followed by an exit. It also reports 2 IPOs and the postponement of 1 listing by 1 fiscal year.